BioAge Labs, Inc.
BIOA
$4.13
-$0.07-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.03% | -11.36% | -- | -- | -- |
| Total Depreciation and Amortization | 5.56% | 3.09% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.90% | -57.98% | -- | -- | -- |
| Change in Net Operating Assets | 254.31% | 66.56% | -- | -- | -- |
| Cash from Operations | -23.66% | -37.90% | -- | -- | -- |
| Capital Expenditure | -410.97% | -120.48% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50,450.97% | -37.59% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -140.00% | -500.00% | -- | -- | -- |
| Issuance of Common Stock | 3,174,900.00% | 5,556,225.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -99.68% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -800.89% | -8,719.05% | -- | -- | -- |
| Cash from Financing | 17.97% | 990.98% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 61.29% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.17% | 12,358.73% | -- | -- | -- |